Adverse Drug Reactions of Acetylcholinesterase Inhibitors in Older People Living with Dementia: A Comprehensive Literature Review

Sirasa Ruangritchankul,1 Prawat Chantharit,2 Sahaphume Srisuma,3 Leonard C Gray4 1Division of Geriatric Medicine, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; 2Division of Infectious Diseases, Department of Medicine, Faculty of Medicine, R...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ruangritchankul S, Chantharit P, Srisuma S, Gray LC
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	older adults dementia acetylcholinesterase inhibitors adverse drug reactions drug-drug interactions Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/d845a195e27141bb925c883f91a3ecfa
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:d845a195e27141bb925c883f91a3ecfa
record_format	dspace
spelling	oai:doaj.org-article:d845a195e27141bb925c883f91a3ecfa2021-12-02T16:32:47ZAdverse Drug Reactions of Acetylcholinesterase Inhibitors in Older People Living with Dementia: A Comprehensive Literature Review1178-203Xhttps://doaj.org/article/d845a195e27141bb925c883f91a3ecfa2021-09-01T00:00:00Zhttps://www.dovepress.com/adverse-drug-reactions-of-acetylcholinesterase-inhibitors-in-older-peo-peer-reviewed-fulltext-article-TCRMhttps://doaj.org/toc/1178-203XSirasa Ruangritchankul,1 Prawat Chantharit,2 Sahaphume Srisuma,3 Leonard C Gray4 1Division of Geriatric Medicine, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; 2Division of Infectious Diseases, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; 3Ramathibodi Poison Center and Division of Clinical Pharmacology and Toxicology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; 4Centre for Health Services Research, Faculty of Medicine, The University of Queensland, Brisbane, QLD, AustraliaCorrespondence: Sirasa RuangritchankulDivision of Geriatric Medicine, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, 270 Rama VI Road, Ratchathewi, Bangkok, 10400, ThailandTel +66 816404373Fax +66 22012588Email sirasarama37@gmail.comAbstract: The rising of global geriatric population has contributed to increased prevalence of dementia. Dementia is a neurodegenerative disease, which is characterized by progressive deterioration of cognitive functions, such as judgment, language, memory, attention and visuospatial ability. Dementia not only has profoundly devastating physical and psychological health outcomes, but it also poses a considerable healthcare expenditure and burdens. Acetylcholinesterase inhibitors (AChEIs), or so-called anti-dementia medications, have been developed to delay the progression of neurocognitive disorders and to decrease healthcare needs. AChEIs have been widely prescribed in clinical practice for the treatment of Alzheimer’s disease, which account for 70% of dementia. The rising use of AChEIs results in increased adverse drug reactions (ADRs) such as cardiovascular and gastrointestinal adverse effects, resulting from overstimulation of peripheral cholinergic activity and muscarinic receptor activation. Changes in pharmacokinetics (PK), pharmacodynamics (PD) and pharmacogenetics (PGx), and occurrence of drug interactions are said to be major risk factors of ADRs of AChEIs in this population. To date, comprehensive reviews in ADRs of AChEIs have so far been scarcely studied. Therefore, we aimed to recapitulate and update the diverse aspects of AChEIs, including the mechanisms of action, characteristics and risk factors of ADRs, and preventive strategies of their ADRs. The collation of this knowledge is essential to facilitate efforts to reduce ADRs of AChEIs.Keywords: older adults, dementia, acetylcholinesterase inhibitors, adverse drug reactions, drug–drug interactionsRuangritchankul SChantharit PSrisuma SGray LCDove Medical Pressarticleolder adultsdementiaacetylcholinesterase inhibitorsadverse drug reactionsdrug-drug interactionsTherapeutics. PharmacologyRM1-950ENTherapeutics and Clinical Risk Management, Vol Volume 17, Pp 927-949 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	older adults dementia acetylcholinesterase inhibitors adverse drug reactions drug-drug interactions Therapeutics. Pharmacology RM1-950
spellingShingle	older adults dementia acetylcholinesterase inhibitors adverse drug reactions drug-drug interactions Therapeutics. Pharmacology RM1-950 Ruangritchankul S Chantharit P Srisuma S Gray LC Adverse Drug Reactions of Acetylcholinesterase Inhibitors in Older People Living with Dementia: A Comprehensive Literature Review
description	Sirasa Ruangritchankul,1 Prawat Chantharit,2 Sahaphume Srisuma,3 Leonard C Gray4 1Division of Geriatric Medicine, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; 2Division of Infectious Diseases, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; 3Ramathibodi Poison Center and Division of Clinical Pharmacology and Toxicology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; 4Centre for Health Services Research, Faculty of Medicine, The University of Queensland, Brisbane, QLD, AustraliaCorrespondence: Sirasa RuangritchankulDivision of Geriatric Medicine, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, 270 Rama VI Road, Ratchathewi, Bangkok, 10400, ThailandTel +66 816404373Fax +66 22012588Email sirasarama37@gmail.comAbstract: The rising of global geriatric population has contributed to increased prevalence of dementia. Dementia is a neurodegenerative disease, which is characterized by progressive deterioration of cognitive functions, such as judgment, language, memory, attention and visuospatial ability. Dementia not only has profoundly devastating physical and psychological health outcomes, but it also poses a considerable healthcare expenditure and burdens. Acetylcholinesterase inhibitors (AChEIs), or so-called anti-dementia medications, have been developed to delay the progression of neurocognitive disorders and to decrease healthcare needs. AChEIs have been widely prescribed in clinical practice for the treatment of Alzheimer’s disease, which account for 70% of dementia. The rising use of AChEIs results in increased adverse drug reactions (ADRs) such as cardiovascular and gastrointestinal adverse effects, resulting from overstimulation of peripheral cholinergic activity and muscarinic receptor activation. Changes in pharmacokinetics (PK), pharmacodynamics (PD) and pharmacogenetics (PGx), and occurrence of drug interactions are said to be major risk factors of ADRs of AChEIs in this population. To date, comprehensive reviews in ADRs of AChEIs have so far been scarcely studied. Therefore, we aimed to recapitulate and update the diverse aspects of AChEIs, including the mechanisms of action, characteristics and risk factors of ADRs, and preventive strategies of their ADRs. The collation of this knowledge is essential to facilitate efforts to reduce ADRs of AChEIs.Keywords: older adults, dementia, acetylcholinesterase inhibitors, adverse drug reactions, drug–drug interactions
format	article
author	Ruangritchankul S Chantharit P Srisuma S Gray LC
author_facet	Ruangritchankul S Chantharit P Srisuma S Gray LC
author_sort	Ruangritchankul S
title	Adverse Drug Reactions of Acetylcholinesterase Inhibitors in Older People Living with Dementia: A Comprehensive Literature Review
title_short	Adverse Drug Reactions of Acetylcholinesterase Inhibitors in Older People Living with Dementia: A Comprehensive Literature Review
title_full	Adverse Drug Reactions of Acetylcholinesterase Inhibitors in Older People Living with Dementia: A Comprehensive Literature Review
title_fullStr	Adverse Drug Reactions of Acetylcholinesterase Inhibitors in Older People Living with Dementia: A Comprehensive Literature Review
title_full_unstemmed	Adverse Drug Reactions of Acetylcholinesterase Inhibitors in Older People Living with Dementia: A Comprehensive Literature Review
title_sort	adverse drug reactions of acetylcholinesterase inhibitors in older people living with dementia: a comprehensive literature review
publisher	Dove Medical Press
publishDate	2021
url	https://doaj.org/article/d845a195e27141bb925c883f91a3ecfa
work_keys_str_mv	AT ruangritchankuls adversedrugreactionsofacetylcholinesteraseinhibitorsinolderpeoplelivingwithdementiaacomprehensiveliteraturereview AT chantharitp adversedrugreactionsofacetylcholinesteraseinhibitorsinolderpeoplelivingwithdementiaacomprehensiveliteraturereview AT srisumas adversedrugreactionsofacetylcholinesteraseinhibitorsinolderpeoplelivingwithdementiaacomprehensiveliteraturereview AT graylc adversedrugreactionsofacetylcholinesteraseinhibitorsinolderpeoplelivingwithdementiaacomprehensiveliteraturereview
_version_	1718383839097651200

Adverse Drug Reactions of Acetylcholinesterase Inhibitors in Older People Living with Dementia: A Comprehensive Literature Review

Ejemplares similares